Efficacy of vancomycin, teicoplanin and fusidic acid as prophylactic agents in prevention of vascular graft infection: An experimental study in rat

European Journal of Vascular and Endovascular Surgery

Volumn 31, Issue 3, 2006, Pages 274-279

  Yasim, Alptekin ^a   Gul, M ^a   Atahan, E ^a   Ciragil, P ^a   Aral, M ^a   Ergun, Y ^a  

^a KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

Author keywords

Antibiotic prophylaxis; Fusidic acid; Rat model; Teicoplanin; Vancomycin; Vascular graft infection

Indexed keywords

FUSIDATE SODIUM; METICILLIN; TEICOPLANIN; VANCOMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIUM CULTURE; BLOOD VESSEL GRAFT; COLONY FORMING UNIT; CONTROLLED STUDY; DACRON VASCULAR PROSTHESIS; DRUG EFFICACY; FEMALE; GRAFT INFECTION; INFECTION PREVENTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RAT; RAT STRAIN; SINGLE DRUG DOSE; STAPHYLOCOCCUS INFECTION; STATISTICAL ANALYSIS;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; BLOOD VESSEL PROSTHESIS; FEMALE; FUSIDIC ACID; INFUSIONS, PARENTERAL; PROSTHESIS-RELATED INFECTIONS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; TEICOPLANIN; VANCOMYCIN;

EID: 33144466139     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejvs.2005.09.018     Document Type: Article

References (22)

1. J. Huh J.C. Chen G.M. Furman C. Malki B. King F. Kafie et. al. Local treatment of prosthetic vascular graft infection with multivesicular liposome-encapsulated amikacin J Surg Res 74 1998 54-58
2. F.J. Lehnhardt G. Torsello L.G.Y. Claeys M. Pfeiffer Z. Wachol-Drewek RT. Grundmann et. al. Systemic and local antibiotic prophylaxis in the prevention of prosthetic vascular graft infection: An experimental study Eur J Vasc Endovasc Surg 23 2002 127-133
3. J.J. Earnshaw Methicillin-resistant Staphylococcus aureus: Vascular surgeons should fight back Eur J Vasc Endovasc Surg 24 2002 283-286
4. L. Jones B.D. Braithwaite B. Davies B.P. Heather J.J. Earnshaw Mechanism of late prosthetic vascular graft infection Cardiovasc Surg 5 1997 486-489
5. M. Vicaretti W.J. Hawthorne P.Y. Ao J.P. Fletcher An increased concentration of rifampicin bonded to gelatin-sealed Dacron reduced the incidence of subsequent graft infections following a staphylococcal challenge Cardiovasc Surg 6 1998 268-273
6. T. Hernandez-Richter H.M. Schardey F. Löhlein MM. Heiss M. Redondo-Müller C. Hammer et. al. The prevention and treatment of vascular graft infection with a triclosan (irgasan)-bonded Dacron graft: an experimental study in the pig Eur J Vasc Endovasc Surg 20 2000 413-418
7. T. Hernandez-Richter H.M. Schardey F. Wittman S. Mayr M. Schmitt-Sody S. Blasenbreu et. al. Rifampin and triclosan but not silver is effective in preventing bacterial infection of vascular Dacron graft material Eur J Vasc Endovasc Surg 26 2003 550-557
8. M. Fujita M. Kinoshita M. Ishihara Y. Kanatani Y. Morimoto M. Simizu et. al. Inhibition of vascular prosthetic graft infection using a photocrosslinkable chitosan hydrogel J Surg Res 121 2004 135-140
9. T. Sago Y. Mori H. Takagi H. Iwata K. Murase Y. Kawamura et. al. Local treatment of Dacron patch graft contaminated with Staphylococcus aureus with antibiotic-releasing porous apatite ceramic: An experimental study in the rabbit J Vasc Surg 37 2003 169-174
10. M. Gabriel F. Pukacki L. Dzieciuchowicz G. Oszkinis P. Checinski Cryopreserved arterial allografts in the treatment of prosthetic graft infections Eur J Vasc Endovasc Surg 27 2004 590-596
11. P.K. Henke T.M. Bergamini S.M. Rose J.D. Richardson Current options in prosthetic vascular graft infection Am Surg 64 1998 39-46
12. R. Ghiselli A. Giacometti O. Cirioni F. Mocchegiani F. Orlando MS. Del Prete et. al. Quinupristin/dalfopristin bonding in combination with intra-peritoneal antibiotics prevent infection of knitted polyester graft material in a subcutaneous rat pouch model infected with resistant Stapylococcus epidermidis Eur J Vasc Endovasc Surg 24 2002 230-234
13. R. Ghiselli A. Giacometti L. Goffi O. Cirioni G. B̈occoli F. Mocchegiani et. al. Efficacy of rifampin-levofloxacin as a prophylactic agent in preventing Staphylococcus epidermidis graft infection Eur J Vasc Endovasc Surg 20 2000 508-511
14. A. Giacometti O. Cirioni R. Ghiselli L. Goffi F. Mocchegiani A. Riva et. al. Policationic peptides as prophylactic agents against methicillin-susceptible or methicillin-resistant Staphylococcus epidermidis vascular graft infection Antimicrob Agents Chemother 44 2000 3306-3309
15. A. Giacometti O. Cirioni R. Ghiselli L. Goffi F. Mocchegiani A. Riva et. al. Efficacy of polycationic peptides in preventing vascular graft infection due to Staphylococcus epidermidis J Antimicrob Chemother 46 2000 751-756
16. R. Ghiselli A. Giacometti L. Goffi O. Cirioni F. Mocchegiani F. Orlando et. al. Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed Dacron J Surg Res 99 2001 316-320
17. A.R. Naylor P.D. Hayes S. Darke A prospective audit of complex wound and graft infections in Great Britain and Ireland: The emergence of MRSA Eur J Vasc Endovasc Surg 21 2001 289-294
18. A. Nasim M.M. Thompson A.R. Naylor P.R.F. Bell N.J.M. London The impact of MRSA on vascular surgery Eur J Vasc Endovasc Surg 22 2001 211-214
19. R. Ghiselli A. Giacometti O. Cirioni G. Dell'Acqua F. Mocchegiani F. Orlando et. al. RNAIII-inhibiting peptide and/or nisin inhibit experimental vascular graft infection with methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis Eur J Vasc Endovasc Surg 27 2004 603-607
20. A. Giacometti O. Cirioni R. Ghiselli L. Goffi C. Viticchi F. Mocchegiani et. al. Mupirocin prophylaxis against methicillin-susceptible, methicillin-resistant, or vancomycin-intermediate Staphylococcus epidermidis vascular graft infection Antimicrob Agents Chemother 44 2000 2842-2844
21. O. Cirioni A. Giacometti R. Ghiselli G. Dell'Acqua Y. Gov W. Kamysz et. al. Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides Circulation 108 2003 767-771
22. G. Ersoz V. Oztuna B. Coskun M.M. Eskandari C. Bayarslan A. Kaya Addition of fusidic acid impregnated bone cement to systemic teicoplanin therapy in the treatment of rat osteomyelitis J Chemother 16 2004 51-55